Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 596789, 10 pages
http://dx.doi.org/10.1155/2015/596789
Research Article

Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation

1Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, China
2National Key Laboratory of Medical Molecular Biology & Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, No. 5 Dongdansantiao, Dongcheng District, Beijing 100005, China

Received 30 July 2014; Accepted 21 August 2014

Academic Editor: Haiteng Deng

Copyright © 2015 Qi Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Manolagas, “Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis,” Endocrine Reviews, vol. 21, no. 2, pp. 115–137, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. E. F. Eriksen, “Cellular mechanisms of bone remodeling,” Reviews in Endocrine and Metabolic Disorders, vol. 11, no. 4, pp. 219–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Manolagas, S. Kousteni, and R. L. Jilka, “Sex steroids and bone,” Recent Progress in Hormone Research, vol. 57, pp. 385–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Syed and S. Khosla, “Mechanisms of sex steroid effects on bone,” Biochemical and Biophysical Research Communications, vol. 328, no. 3, pp. 688–696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Nakamura, Y. Imai, T. Matsumoto et al., “Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts,” Cell, vol. 130, no. 5, pp. 811–823, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Mano, Y. Hakeda, and M. Kumegawa, “Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor α,” Cytotechnology, vol. 35, no. 1, pp. 17–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kameda, H. Mano, T. Yuasa et al., “Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts,” Journal of Experimental Medicine, vol. 186, no. 4, pp. 489–495, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. N. K. Shevde, A. C. Bendixen, K. M. Dienger, and J. W. Pike, “Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 7829–7834, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Saintier, M.-A. Burde, J. M. Rey, T. Maudelonde, M. C. de Vernejoul, and M. E. Cohen-Solal, “17β-estradiol downregulates β3-integrin expression in differentiating and mature human osteoclasts,” Journal of Cellular Physiology, vol. 198, no. 2, pp. 269–276, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. B. F. Boyce, “Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts,” Journal of Bone and Mineral Research, vol. 28, no. 4, pp. 711–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Takayanagi, “Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems,” Nature Reviews Immunology, vol. 7, no. 4, pp. 292–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. W. J. Boyle, W. S. Simonet, and D. L. Lacey, “Osteoclast differentiation and activation,” Nature, vol. 423, no. 6937, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Kobayashi, Y. Kadono, A. Naito et al., “Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis,” EMBO Journal, vol. 20, no. 6, pp. 1271–1280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. F. Wagner and R. Eferl, “Fos/AP-1 proteins in bone and the immune system,” Immunological Reviews, vol. 208, pp. 126–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Hu, S. M. Sharma, A. Bronisz, R. Srinivasan, U. Sankar, and M. C. Ostrowski, “Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors,” Molecular and Cellular Biology, vol. 27, no. 11, pp. 4018–4027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Negishi-Koga and H. Takayanagi, “Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation,” Immunological Reviews, vol. 231, no. 1, pp. 241–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Wu, G. Pan, M. A. McKenna, M. Zayzafoon, W.-C. Xiong, and J. M. McDonald, “RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts,” Journal of Bone and Mineral Research, vol. 20, no. 1, pp. 107–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Nakamura, L. T. Duong, S. B. Rodan, and G. A. Rodan, “Involvement of αvβ3 integrins in osteoclast function,” Journal of Bone and Mineral Metabolism, vol. 25, no. 6, pp. 337–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Zou and S. L. Teitelbaum, “Integrins, growth factors, and the osteoclast cytoskeleton,” Annals of the New York Academy of Sciences, vol. 1192, pp. 27–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. P. McHugh, K. Hodivala-Dilke, M.-H. Zheng et al., “Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts,” Journal of Clinical Investigation, vol. 105, no. 4, pp. 433–440, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Itzstein, F. P. Coxon, and M. J. Rogers, “The regulation of osteoclast function and bone resorption by small GTPases,” Small GTPases, vol. 2, no. 3, pp. 117–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Vincent, M. Kogawa, D. M. Findlay, and G. J. Atkins, “The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions,” Journal of Bone and Mineral Metabolism, vol. 27, no. 1, pp. 114–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Xiong, A. Darwanto, S. Sharma et al., “Mass spectrometric studies on epigenetic interaction networks in cell differentiation,” The Journal of Biological Chemistry, vol. 286, no. 15, pp. 13657–13668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. P. van Ulsen Karsten Kuhn, T. Prinz, H. Legner, P. Schmid, C. Baumann, and J. Tommassen, “Identification of proteins of Neisseria meningitidis induced under iron-limiting conditions using the isobaric tandem mass tag (TMT) labeling approach,” Proteomics, vol. 9, no. 7, pp. 1771–1781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Chen, Y. Ouyang, T. Ye, B. Ni, and A. Chen, “Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel,” The Journal of Cellular Biochemistry, vol. 115, no. 4, pp. 651–658, 2014. View at Publisher · View at Google Scholar
  26. S. Srivastava, G. Toraldo, M. N. Weitzmann, S. Cenci, F. P. Ross, and R. Pacifici, “Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation,” The Journal of Biological Chemistry, vol. 276, no. 12, pp. 8836–8840, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. V. G. Palacios, L. J. Robinson, C. W. Borysenko, T. Lehmann, S. E. Kalla, and H. C. Blair, “Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens,” Journal of Biological Chemistry, vol. 280, no. 14, pp. 13720–13727, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. X. L. Shi, C. W. Li, Q. Z. Wan, A. Q. Li, H. Wang, and K. Liu, “Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats,” Genetics and Molecular Research, vol. 13, no. 2, pp. 4311–4319, 2014. View at Google Scholar
  29. H. C. Blair, S. L. Teitelbaum, R. Ghiselli, and S. Gluck, “Osteoclastic bone resorption by a polarized vacuolar proton pump,” Science, vol. 245, no. 4920, pp. 855–857, 1989. View at Publisher · View at Google Scholar · View at Scopus
  30. A. E. Kearns, S. Khosla, and P. J. Kostenuik, “Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease,” Endocrine Reviews, vol. 29, no. 2, pp. 155–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. H. Lee and H.-H. Kim, “Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts,” Biochemical and Biophysical Research Communications, vol. 305, no. 2, pp. 211–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. L. Burgess, Y.-X. Qian, S. Kaufman et al., “The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts,” Journal of Cell Biology, vol. 145, no. 3, pp. 527–538, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Saintier, V. Khanine, B. Uzan, H. K. Ea, M. C. de Vernejoul, and M. E. Cohen-Solal, “Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro,” Journal of Steroid Biochemistry and Molecular Biology, vol. 99, no. 4-5, pp. 165–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. T. J. Chambers and K. Fuller, “How are osteoclasts induced to resorb bone?” Annals of the New York Academy of Sciences, vol. 1240, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Zhang, N. Udagawa, I. Nakamura et al., “The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts,” Journal of Cell Science, vol. 108, part 6, pp. 2285–2292, 1995. View at Google Scholar · View at Scopus
  36. F. Saltel, O. Destaing, F. Bard, D. Eichert, and P. Jurdic, “Apatite-mediated actin dynamics in resorbing osteoclasts,” Molecular Biology of the Cell, vol. 15, no. 12, pp. 5231–5241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Ory, Y. Munari-Silem, P. Fort, and P. Jurdic, “Rho and Rac exert antagonistic functions on spreading of macrophage-derived multinucleated cells and are not required for actin fiber formation,” Journal of Cell Science, vol. 113, part 7, pp. 1177–1188, 2000. View at Google Scholar · View at Scopus
  38. M. A. Chellaiah, N. Soga, S. Swanson et al., “Rho-A is critical for osteoclast podosome organization, motility, and bone resorption,” The Journal of Biological Chemistry, vol. 275, no. 16, pp. 11993–12002, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. V. W. Engleman, G. A. Nickols, F. P. Ross et al., “A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo,” Journal of Clinical Investigation, vol. 99, no. 9, pp. 2284–2292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Zhao, F. P. Ross, and S. L. Teitelbaum, “Unoccupied αvβ3 integrin regulates osteoclast apoptosis by transmitting a positive death signal,” Molecular Endocrinology, vol. 19, no. 3, pp. 771–780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Thurston and J. Kitajewski, “VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis,” British Journal of Cancer, vol. 99, no. 8, pp. 1204–1209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Tanaka, M. Abe, M. Hiasa et al., “Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin,” Clinical Cancer Research, vol. 13, no. 3, pp. 816–823, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. F. C. Cackowski, J. L. Anderson, K. D. Patrene et al., “Osteoclasts are important for bone angiogenesis,” Blood, vol. 115, no. 1, pp. 140–149, 2010. View at Publisher · View at Google Scholar · View at Scopus